“Serious adverse event” in AstraZeneca’s COVID-19 vaccine trial revealed as spinal inflammation disorder caused by toxic adjuvants

Thursday, September 10, 2020
By Paul Martin

by: Ethan Huff
NaturalNews.com
Thursday, September 10, 2020

It has finally been revealed that the participant in AstraZeneca’s Wuhan coronavirus (COVID-19) vaccine trial who suffered a “serious adverse event,” causing a global shutdown of the company’s entire phase-three trial, developed a spinal inflammatory disorder known as transverse myelitis.

Company CEO Pascal Soriot told JP Morgan and other investors over a conference call that the woman from the United Kingdom developed neurological symptoms consistent with this “rare” disease almost immediately following injection, though AstraZeneca insists that the experimental vaccine is not to blame.

The woman is said to be “improving,” and will likely be released from the hospital in the next few days. In the meantime, AstraZeneca, which partnered with the University of Oxford to develop the vaccine that injured her, is trying to figure out when it might resume the phase-three trial to get the vaccine released in time for the election, upon request from President Donald Trump.

Soriot’s comments, according to one of the investors who participated in the call, were apparently intended to reassure everyone that the company was taking the vaccine safety event seriously. The goal was to convey to investors that everything is just fine and moving right along, despite this minor hiccup.

This is actually the SECOND case of neurological damage caused by AstraZeneca’s COVID-19 vaccine

The Rest…HERE

One Response to ““Serious adverse event” in AstraZeneca’s COVID-19 vaccine trial revealed as spinal inflammation disorder caused by toxic adjuvants”

  1. Citizen Kane

    No sympathy for that idiot woman who allowed herself to be their lab rat. I hope the money they paid you was worth it.

    #14529
Join the revolution in 2018. Revolution Radio is 100% volunteer ran. Any contributions are greatly appreciated. God bless!

Follow us on Twitter